Skip to main content

New Grant Awarded! R01 DA058933

We received notification that our R01 on xylazine and fentanyl co-use will be funded by NIDA on June 15, titled “Neurobehavioral mechanisms of xylazine and fentanyl co-use and withdrawal. This grant will determine the behavioral and neurobiological impacts of xylazine adulteration of intravenously self-administered fentanyl in collaboration with Dr. Terry Hinds, Jr., and will utilize his state-of-the-art Pamgene Pamstation to uncover novel targets to reverse overdose.